Cargando…
C-terminal modification of the insulin B:11–23 peptide creates superagonists in mouse and human type 1 diabetes
A polymorphism at β57 in some major histocompatibility complex class II (MHCII) alleles of rodents and humans is associated with a high risk for developing type 1 diabetes (T1D). However, a highly diabetogenic insulin B chain epitope within the B:9–23 peptide is presented poorly by these alleles to...
Autores principales: | Wang, Yang, Sosinowski, Tomasz, Novikov, Andrey, Crawford, Frances, Neau, David B., Yang, Junbao, Kwok, William W., Marrack, Philippa, Kappler, John W., Dai, Shaodong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
National Academy of Sciences
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5776820/ https://www.ncbi.nlm.nih.gov/pubmed/29255035 http://dx.doi.org/10.1073/pnas.1716527115 |
Ejemplares similares
-
Structures suggest an approach for converting weak self-peptide tumor antigens into superagonists for CD8 T cells in cancer
por: Wei, Pengcheng, et al.
Publicado: (2021) -
Structural Basis of Cytochrome c Presentation by IE(k)
por: Fremont, Daved H., et al.
Publicado: (2002) -
Lysosomal cathepsin creates chimeric epitopes for diabetogenic CD4 T cells via transpeptidation
por: Reed, Brendan, et al.
Publicado: (2020) -
Mimotopes for Alloreactive and Conventional T Cells in a Peptide–MHC Display Library
por: Crawford, Frances, et al.
Publicado: (2004) -
Influence of the NH(2)-terminal Amino Acid of the T Cell Receptor α Chain on Major Histocompatibility Complex (MHC) Class II + Peptide Recognition
por: Seibel, Jeffrey L., et al.
Publicado: (1997)